When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EMMA - Emmaus Life Sciences drug to reduce sickle cell disease granted orphan drug status in Switzerland
Emmaus Life Sciences Incorporation
Emmaus Life Sciences ([[EMMA]]) announces that the Swiss Agency for Therapeutic Products has granted orphan drug status to Endari. Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.The drug also enjoys Orphan Drug status and Orphan Medicinal status in the United States and the European Union, respectively.Press Release